|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| C12Q 1/70 | |||
| C12Q 1/04 | |||
| A61K 49/00 | |||
| A61K 49/06 | |||
| A61K 39/395 |
| (11) | Number of the document | 1863940 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06769770.6 |
| Date of filing the European patent application | 2006-02-24 | |
| (97) | Date of publication of the European application | 2007-12-12 |
| (45) | Date of publication and mention of the grant of the patent | 2012-06-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/006723 |
| Date | 2006-02-24 |
| (87) | Number | WO 2006/112951 |
| Date | 2006-10-26 |
| (30) | Number | Date | Country code |
| 658335 P | 2005-03-03 | US |
| (72) |
RUBIN, Keith H., US
GLAZER, Steven, US
|
| (73) |
Seedlings Life Science Ventures, LLC.,
770 Broadway 2nd Floor/power Space, New York, NY 10003,
US
|
| (54) | METHOD OF RISK MANAGEMENT FOR PATIENTS UNDERGOING NATALIZUMAB TREATMENT |
| METHOD OF RISK MANAGEMENT FOR PATIENTS UNDERGOING NATALIZUMAB TREATMENT |